307 related articles for article (PubMed ID: 15482539)
1. Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan.
Satoh Y; Hino K; Kato T; Mizokami M; Yamashita S; Nakamura H; Okita K
J Gastroenterol Hepatol; 2004 Nov; 19(11):1305-11. PubMed ID: 15482539
[TBL] [Abstract][Full Text] [Related]
2. Identification and phylogenetic analysis of hepatitis C virus in forensic blood samples obtained from injecting drug users.
Kato H; Maeno Y; Seko-Nakamura Y; Monma-Ohtaki J; Sugiura S; Takahashi K; Zhe LX; Matsumoto T; Kurvanov F; Mizokami M; Nagao M
Forensic Sci Int; 2007 May; 168(1):27-33. PubMed ID: 16829004
[TBL] [Abstract][Full Text] [Related]
3. Extremely high prevalence and genetic diversity of hepatitis C virus infection among HIV-infected injection drug users in Taiwan.
Liu JY; Lin HH; Liu YC; Lee SS; Chen YL; Hung CC; Ko WC; Huang CK; Lai CH; Chen YS; Shih YL; Chung HC; Liang SH; Lin JN
Clin Infect Dis; 2008 Jun; 46(11):1761-8. PubMed ID: 18433337
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus prevalence and outcomes among injecting drug users on opioid replacement therapy.
Hallinan R; Byrne A; Amin J; Dore GJ
J Gastroenterol Hepatol; 2005 Jul; 20(7):1082-6. PubMed ID: 15955218
[TBL] [Abstract][Full Text] [Related]
5. Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales.
Sutton AJ; Gay NJ; Edmunds WJ; Hope VD; Gill ON; Hickman M
BMC Infect Dis; 2006 Jun; 6():93. PubMed ID: 16762050
[TBL] [Abstract][Full Text] [Related]
6. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
[TBL] [Abstract][Full Text] [Related]
7. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands.
van de Laar TJ; Koppelman MH; van der Bij AK; Zaaijer HL; Cuijpers HT; van der Poel CL; Coutinho RA; Bruisten SM
Transfusion; 2006 Oct; 46(10):1719-28. PubMed ID: 17002628
[TBL] [Abstract][Full Text] [Related]
8. [Study on the epidemiology and distribution of human immunodeficiency virus-1 and hepatitis C virus infection among intravenous drug users and illegal blood donors in China].
Yin N; Mei S; Li L; Wei FL; Zhang LQ; Cao YZ
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):962-5. PubMed ID: 14687492
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus molecular epidemiology in Uzbekistan.
Kurbanov F; Tanaka Y; Sugauchi F; Kato H; Ruzibakiev R; Zalyalieva M; Yunusova Z; Mizokami M
J Med Virol; 2003 Mar; 69(3):367-75. PubMed ID: 12526047
[TBL] [Abstract][Full Text] [Related]
10. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus (HCV) 5'NC sequence variants and their association with hepatitis C risk groups.
Krekulova L; Rehak V; Riley LW
J Clin Virol; 2005 Apr; 32(4):300-4. PubMed ID: 15780809
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection, HIV co-infection, and associated risk among injecting drug users in Togliatti, Russia.
Rhodes T; Platt L; Judd A; Mikhailova LA; Sarang A; Wallis N; Alpatova T; Hickman M; Parry JV
Int J STD AIDS; 2005 Nov; 16(11):749-54. PubMed ID: 16303071
[TBL] [Abstract][Full Text] [Related]
13. Epidemiological and genetic analyses of Hepatitis C virus transmission among young/short- and long-term injecting drug users from Rio de Janeiro, Brazil.
Oliveira Mde L; Bastos FI; Telles PR; Hacker Mde A; Oliveira SA; Miguel JC; Yoshida CF
J Clin Virol; 2009 Mar; 44(3):200-6. PubMed ID: 19195927
[TBL] [Abstract][Full Text] [Related]
14. Consecutive infections and clearances of different hepatitis C virus genotypes in an injecting drug user.
Aitken CK; Tracy SL; Revill P; Bharadwaj M; Bowden DS; Winter RJ; Hellard ME
J Clin Virol; 2008 Apr; 41(4):293-6. PubMed ID: 18242125
[TBL] [Abstract][Full Text] [Related]
15. Coinfection with HIV and hepatitis C virus among injection drug users in southern China.
Garten RJ; Zhang J; Lai S; Liu W; Chen J; Yu XF
Clin Infect Dis; 2005 Jul; 41 Suppl 1():S18-24. PubMed ID: 16265609
[TBL] [Abstract][Full Text] [Related]
16. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.
Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H
Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992
[TBL] [Abstract][Full Text] [Related]
18. [Current situation and trends in the hepatitis C virus genotype distribution among injecting drug users in the Czech Republic].
Krekulová L; Rehák V; Strunecký O; Nēmecek V
Epidemiol Mikrobiol Imunol; 2009 Apr; 58(2):84-9. PubMed ID: 19526922
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with hepatitis C virus infection in injection and noninjection drug users in Italy.
Quaglio G; Lugoboni F; Pajusco B; Sarti M; Talamini G; Lechi A; Mezzelani P; Des Jarlais DC
Clin Infect Dis; 2003 Jul; 37(1):33-40. PubMed ID: 12830406
[TBL] [Abstract][Full Text] [Related]
20. High incidence of hepatitis C virus reinfection within a cohort of injecting drug users.
Micallef JM; Macdonald V; Jauncey M; Amin J; Rawlinson W; van Beek I; Kaldor JM; White PA; Dore GJ
J Viral Hepat; 2007 Jun; 14(6):413-8. PubMed ID: 17501762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
